(untitled) - Zinman, B; Wanner, C; Lachin, J M
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. The New England Journal of Medicine 2015; 373: doi:10.1056/NEJMoa1504720